European stocks closed mostly higher to extend the positive momentum this week on strength in healthcare and luxury brands. The Eurozone's STOXX 50 inched higher to 5,651 and the pan-European STOXX 600 rose 0.5% to 570, both at record highs. Sanofi, Novo Nordisk, Merck, and UCB rose more than 2%, extending their surge this week after the US Presidential Administration signaled that tariffs on pharmaceutical goods may be less aggressive than feared, while allowing patients to buy discounted prescription drugs through a new federal website. Luxury giants were also higher as markets assessed...
The Nikkei 225 Index surged 1.13% to 36,452, while the broader Topix Index rose 0.46% to 2,679 on Thursday, with Japanese equities hitting a one-month high after the Bank of Japan kept its policy rate unchanged at 0.5%, as expected. Investor sentiment was further boosted by a dovish tilt in the BOJ's outlook, as the central bank cut its growth and inflation forecasts, signaling a lower likelihood of near-term rate hikes. The BOJ now projects GDP growth of 0.5% in 2025, down from 1% in its January forecast. Markets also welcomed renewed optimism over US-Japan trade talks, after President...
The Nikkei 225 Index climbed 0.5% on Thursday to surpass 36,200, reaching a one-month high as investors looked ahead to the Bank of Japan's latest monetary policy decision. The central bank is widely expected to keep its policy rate steady at 0.5%, as it assesses the possible effects of newly imposed US tariffs on Japan's export-reliant economy. Japanese shares also took cues from a positive lead on Wall Street , where investors brushed aside recession concerns after the US economy unexpectedly contracted in the first quarter. Adding to market optimism, hopes for progress in US-Japan trade...
The Nikkei 225 index rose 0.5% on Thursday to surpass 36,200, hitting a one-month high as investors awaited the Bank of Japan's latest monetary policy decision. The central bank is widely expected to keep its policy interest rate unchanged at 0.5%, as it assesses the likely impact of new U.S. tariffs on Japan's export-dependent economy. Japanese stocks also took cues from the upbeat outlook on Wall Street, where investors brushed aside recession fears after the U.S. economy unexpectedly contracted in the first quarter. Adding to market optimism, hopes for progress in U.S.-Japan trade talks...
The S&P 500 and Dow reversed early losses, rising 0.1% and 0.3%, respectively, to extend their winning streak to seven days, while the Nasdaq closed 0.1% lower. Investors shrugged off recession fears despite data showing the first quarterly economic contraction in three years. The U.S. economy shrank 0.3% in the first quarter, missing expectations as businesses rushed to import goods before Trump's tariffs took effect, while consumer spending rose a stronger-than-expected 0.7% in March, weak hiring and reduced government spending highlighting the growing economic headwinds. Among stocks,...
European stocks closed mixed on Wednesday, with the Stoxx 50 down 0.5% while the Stoxx 600 gained 0.5% for a seventh straight session, as investors digested a wave of earnings and downbeat U.S. economic data. Despite early losses, gains in health care and banking helped the market recover. Autos fell 1.2%, as weak earnings overshadowed President Trump's order to ease some auto tariffs. Health care stocks rose 1.3%, with GSK, AstraZeneca and Smith+Nephew saying they were prepared for the impact of tariffs. UBS beat expectations with earnings of $1.692 billion, while Barclays also beat...